These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19888337)

  • 1. Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen.
    Sharlow ER; Close D; Shun T; Leimgruber S; Reed R; Mustata G; Wipf P; Johnson J; O'Neil M; Grögl M; Magill AJ; Lazo JS
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e540. PubMed ID: 19888337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
    Caridha D; Parriot S; Hudson TH; Lang T; Ngundam F; Leed S; Sena J; Harris M; O'Neil M; Sciotti R; Read L; Lecoeur H; Hickman M; Grogl M
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by
    Rodriguez F; Iniguez E; Pena Contreras G; Ahmed H; Costa TEMM; Skouta R; Maldonado RA
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29973498
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel Leishmania major amastigote assay in 96-well format for rapid drug screening and its use for discovery and evaluation of a new class of leishmanicidal quinolinium salts.
    Bringmann G; Thomale K; Bischof S; Schneider C; Schultheis M; Schwarz T; Moll H; Schurigt U
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3003-11. PubMed ID: 23587955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
    Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
    J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by high-throughput screening of small-molecule chemical library.
    Lackovic K; Parisot JP; Sleebs N; Baell JB; Debien L; Watson KG; Curtis JM; Handman E; Street IP; Kedzierski L
    Antimicrob Agents Chemother; 2010 May; 54(5):1712-9. PubMed ID: 20160053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.
    Sadeghi S; Seyed N; Etemadzadeh MH; Abediankenari S; Rafati S; Taheri T
    Korean J Parasitol; 2015 Aug; 53(4):385-94. PubMed ID: 26323836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.
    Walker RG; Thomson G; Malone K; Nowicki MW; Brown E; Blake DG; Turner NJ; Walkinshaw MD; Grant KM; Mottram JC
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1033. PubMed ID: 21483720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.
    Ortiz D; Guiguemde WA; Hammill JT; Carrillo AK; Chen Y; Connelly M; Stalheim K; Elya C; Johnson A; Min J; Shelat A; Smithson DC; Yang L; Zhu F; Guy RK; Landfear SM
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006157. PubMed ID: 29287089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit.
    De Muylder G; Ang KK; Chen S; Arkin MR; Engel JC; McKerrow JH
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1253. PubMed ID: 21811648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.
    Nühs A; De Rycker M; Manthri S; Comer E; Scherer CA; Schreiber SL; Ioset JR; Gray DW
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004094. PubMed ID: 26407168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
    Shimony O; Jaffe CL
    J Microbiol Methods; 2008 Oct; 75(2):196-200. PubMed ID: 18573286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanicidal Activity of Isoselenocyanate Derivatives.
    Fernández-Rubio C; Larrea E; Peña Guerrero J; Sesma Herrero E; Gamboa I; Berrio C; Plano D; Amin S; Sharma AK; Nguewa PA
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Antileishmanial Chemotypes By High-Throughput Virtual and In Vitro Screening.
    Khan H; Hakami MA; Alamri MA; Alotaibi BS; Ullah N; Khan R; Khalid A; Abdalla AN; Wadood A
    Acta Parasitol; 2024 Sep; 69(3):1439-1457. PubMed ID: 39150581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Bioluminescent Monitoring of Parasites in BALB/c Mouse Models of Cutaneous Leishmaniasis Drug Discovery.
    Caridha D; Leed S; Cawlfield A
    Methods Mol Biol; 2020; 2081():81-106. PubMed ID: 31721120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds.
    Corman HN; Shoue DA; Norris-Mullins B; Melancon BJ; Morales MA; McDowell MA
    Int J Antimicrob Agents; 2019 Oct; 54(4):496-501. PubMed ID: 31323307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study.
    Khalili S; Ebrahimzade E; Mohebali M; Shayan P; Mohammadi-Yeganeh S; Moosazadeh Moghaddam M; Elikaee S; Akhoundi B; Sharifi-Yazdi MK
    Exp Parasitol; 2019 Jan; 196():48-54. PubMed ID: 30496731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.
    Mikus J; Steverding D
    Parasitol Int; 2000 Jan; 48(3):265-9. PubMed ID: 11227767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
    Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
    ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decanethiol functionalized silver nanoparticles are new powerful leishmanicidals in vitro.
    Isaac-Márquez AP; Talamás-Rohana P; Galindo-Sevilla N; Gaitan-Puch SE; Díaz-Díaz NA; Hernández-Ballina GA; Lezama-Dávila CM
    World J Microbiol Biotechnol; 2018 Feb; 34(3):38. PubMed ID: 29460068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.